Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling

1 Nov 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Mechanisms and Therapy
Share to TGF-β signaling in diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23178117
DOI: 10.1016/j.cell.2012.10.035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor SignalingPMID 23178117Read ↗

MED12 dysregulation: insights into cancer and therapeutic resistance.Semantic proximity Read ↗

SMAD-oncoprotein interplay: Potential determining factors in targeted therapiesSemantic proximity Read ↗

BMP2 as a promising anticancer approach: functions and molecular mechanismsSemantic proximity Read ↗

Association of SMAD4 loss with drug resistance in clinical cancer patients: A systematic meta-analysisSemantic proximity Read ↗

Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and ProgressionSemantic proximity Read ↗

MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokinesSemantic proximity Read ↗

SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell linesSemantic proximity Read ↗

Mediating Resistance in Oncogene-Driven CancersSemantic proximity Read ↗

miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1Semantic proximity Read ↗

Drm/Gremlin transcriptionally activates p21Cip1 via a novel mechanism and inhibits neoplastic transformationSemantic proximity Read ↗

Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategySemantic proximity Read ↗

Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.